Contact Us

Stage 1A Non-Small Cell Lung Cancer Found in Right Upper Lobe

SPiN ACCESS CATHETER™ REACHES RIGHT UPPER LOBE NODULE
Author
Dr. Johnathan Grant

Internal Medicine, Pulmonary Disease & Critical Care Medicine

Good Samaritan Hospital

Vincennes, IN

Patient Information: 67 y/o, M

Scan Protocol: Veran Inspiration/Expiration CT Scan Protocol

Nodule: RUL 17mm

Target Motion: 5.6mm

Biopsy Result: Adenocarcinoma

Instruments Used: SPiN Access Catheter™, Always-On Tip Tracked® Serrated Forceps, 19ga Needle & Brush

Conclusion: Stereotactic Body Radiation Therapy (SBRT)

Observations

“Having the SPiN Access Catheter™ during this particular case helped us get a diagnosis. The SPiN Access Catheter™ is much easier to use than other competitors and you can feel the various segments when using the catheter. I think that is why this tool will be very useful and successful in future cases.”

Patient History
This 67-year-old male patient was referred to Dr. Grant for biopsy of a right upper lobe (RUL) lung nodule. This was an incidental finding that was noted upon inspection of a CT scan for chest pain. A 3mm nodule was noted in the RUL and a 4mm nodule was noted in the right lower lobe (RLL). Upon follow-up, it was discovered the RLL nodule disappeared and the RUL nodule increased in size to 13mm.

Planning
Dr. Grant utilized SPiN Planning™ software to segment the nodule located in the RUL. The nodule was 17mm in size and moving 5.6mm between respiratory phases. Due to the target’s location within the RUL, Dr. Grant decided that he would utilize the SPiN Access Catheter™ during this procedure to reach the area of interest.

Procedure
Dr. Grant started the procedure with the SPiN System™. He utilized the SPiN Access Catheter™ to successfully reach the RUL nodule. Once in position, Dr. Grant used tip-tracked serrated forceps, 19ga needle, and brush to obtain biopsies of the nodule. After obtaining adequate biopsies, Dr. Grant concluded the procedure with linear EBUS in order to stage the mediastinum. The final pathological report revealed stage 1A Adenocarcinoma and the patient was referred for SBRT.

Schedule a Demo